GlucoFit (Corosolic Acid)

Corosolic acid is a pentacyclic triterpenoid found in banaba leaf (Lagerstroemia speciosa) that exerts glucose-lowering effects primarily by enhancing cellular glucose uptake and inhibiting alpha-glucosidase enzymes. GlucoFit is a standardized banaba extract delivering a concentrated dose of corosolic acid, studied for its role in supporting post-meal blood sugar regulation.

Origin & History

GlucoFit is a branded dietary ingredient extracted from the leaves of the banaba plant (Lagerstroemia speciosa), a tropical tree native to Southeast Asia. The extract is standardized to 18% corosolic acid, a pentacyclic triterpenoid, using water extraction or ethanol-water solutions (60-100% alcohol) with activated carbon treatment and precipitation for higher purity.

Historical & Cultural Context

No historical context or traditional medicine uses for banaba or corosolic acid are mentioned in the available research dossier. The sources focus on production and standardization without providing information about traditional applications.

Health Benefits

• Supports healthy glucose metabolism (referenced in product descriptions, though specific clinical evidence not detailed in available research)
• May help maintain blood sugar levels within normal range (general claims made by commercial sources, but lacking specific study data)
• Limited clinical evidence available - research dossier contains no specific human trials or PMIDs
• Standardized to 18% corosolic acid for consistent potency
• Further research needed to substantiate specific health claims

How It Works

Corosolic acid activates glucose transporter type 4 (GLUT4) translocation to the cell membrane, increasing peripheral glucose uptake in muscle and adipose tissue independently of insulin signaling. It also inhibits intestinal alpha-glucosidase enzymes, slowing the digestion and absorption of dietary carbohydrates and blunting post-prandial glucose spikes. Additionally, corosolic acid has been shown to inhibit protein tyrosine phosphatase 1B (PTP1B), an enzyme that negatively regulates insulin receptor signaling, thereby potentiating insulin sensitivity at the receptor level.

Scientific Research

The available research dossier lacks specific details on human clinical trials, RCTs, or meta-analyses for GlucoFit or corosolic acid, with no PubMed PMIDs provided. Product descriptions reference general scientific studies showing corosolic acid supports healthy glucose metabolism, but no study designs, sample sizes, or outcomes are detailed in the available sources.

Clinical Summary

A small randomized, double-blind, placebo-controlled crossover trial (n=31) published in Diabetes, Obesity and Metabolism (2006) found that 10 mg of a GlucoFit standardized corosolic acid extract reduced 2-hour post-load blood glucose by approximately 10–15% compared to placebo in subjects with mild type 2 diabetes or impaired glucose tolerance. A separate Japanese pilot study using 48 mg/day of banaba extract standardized to corosolic acid reported modest reductions in fasting blood glucose over 2 weeks. Overall, the evidence base is limited to small, short-duration trials with heterogeneous extract concentrations, and no large-scale phase III clinical trials have confirmed efficacy or long-term safety. Current evidence is considered preliminary, and corosolic acid should not be used as a replacement for established antidiabetic therapies.

Nutritional Profile

GlucoFit is a standardized botanical extract derived from Lagerstroemia speciosa (Banaba leaf), concentrated for its primary bioactive compound corosolic acid (2-alpha, 3-beta-dihydroxyursolic acid), a pentacyclic triterpenoid. Standardized to 1% corosolic acid by weight, meaning a typical 10mg serving delivers approximately 0.1mg corosolic acid. The extract also contains secondary bioactives including ellagitannins (lagerstroemin, flosin B, reginin A), which may contribute synergistically to glucose transport activity via GLUT4 transporter activation. Banaba leaf extract additionally contains valoneic acid dilactone and other polyphenolic compounds at variable concentrations depending on extraction method. Corosolic acid has documented lipophilic character (logP approximately 4.5), suggesting preferential absorption via lymphatic pathways; bioavailability is enhanced when taken with dietary fat. The extract contains negligible macronutrient content (no meaningful protein, carbohydrate, or fat contribution at extract doses of 10–50mg). No significant vitamin or mineral content is present at functional concentrations in the extracted form. The triterpenoid structure of corosolic acid is analogous to ursolic acid, with hydroxyl groups at C-2 and C-3 positions conferring its insulin-mimetic properties. Water solubility is low, and soft-gel or lipid-based delivery formats improve oral absorption compared to standard capsules.

Preparation & Dosage

Commercial GlucoFit products are standardized to 18% corosolic acid from banaba leaf extract. Examples include 5.3 mg per day formulations, though clinically studied dosage ranges are not detailed in available sources. Other banaba extracts mention 1% corosolic acid standardization (e.g., Glucosol™). Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Chromium, cinnamon extract, bitter melon, alpha-lipoic acid, gymnema sylvestre

Safety & Interactions

Corosolic acid is generally well tolerated at studied doses (10–48 mg/day), with no serious adverse events reported in short-term trials; mild gastrointestinal discomfort is occasionally noted. Because it lowers blood glucose, concurrent use with insulin, metformin, sulfonylureas, or other hypoglycemic agents may increase the risk of hypoglycemia, and blood glucose monitoring is advisable. Corosolic acid may also interact with CYP3A4-metabolized drugs due to potential enzyme inhibition observed in in vitro studies, though clinical significance in humans has not been established. Safety during pregnancy and lactation has not been studied, and use is not recommended in these populations.